This is the authors' abstract. We don't add key points for this paper.
Rationale Post‐test probabilities are reported as precise numbers even though the pretest probabilities they depend on are uncertain and, for an individual patient, unobservable. Clinicians need a way to tell the mathematical question—how strongly is a change in the pretest estimate carried through to the post‐test probability—apart from the clinical question of whether the remaining uncertainty is wide enough to alter management. Aims and Objectives To show that the prevalence threshold () marks the tipping point at which uncertainty expressed in percentage points is passed on unchanged by a positive test result, and to combine that result with exact conversion of pretest ranges and with the clinician's own action threshold. Method Conceptual and analytic study, supported by a targeted narrative overview of pretest‐probability estimation and of cognitive influences on diagnostic reasoning. We derived how strongly the positive‐result screening curve responds to a change in the pretest probability, examined how that result depends on the scale used, distinguished from testing and treatment thresholds, and applied the framework to a primary care example. Results For a positive likelihood ratio is the single pretest probability at which one percentage point of pretest uncertainty becomes one percentage point of post‐test uncertainty. Below such changes are magnified; above it they are damped. The tipping point exists only when uncertainty is measured in percentage points, because a positive result multiplies the odds by the same factor at every pretest probability. In a worked primary care example (, the order of magnitude of a positive urinary nitrite), a pretest estimate of 15% gives a post‐test probability of 58.5%, and a plausible pretest range of 10%–25% converts exactly to 47.1%–72.7%. That range straddles a 50% action threshold but not a 40% or an 80% one; itself settles nothing. Conclusion The prevalence threshold is a closed‐form description of how uncertainty travels through a positive test result, not a decision rule and not a guarantee of precision. Its useful role is to prompt clinicians to state a pretest range, convert it, and compare the result with the probability at which they would act differently. Vignette and human‐factors studies with clinicians are needed before clinical implementation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nadler et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: